Detalles de la búsqueda
1.
Perioperative Nivolumab in Resectable Lung Cancer.
N Engl J Med
; 390(19): 1756-1769, 2024 May 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38749033
2.
The Relationship Between Health-Related Quality of Life and Overall Survival in Patients With Advanced Renal Cell Carcinoma in CheckMate 214.
Oncologist
; 29(6): 511-518, 2024 Jun 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38280218
3.
Patient-reported outcomes with first-line nivolumab plus cabozantinib versus sunitinib in patients with advanced renal cell carcinoma treated in CheckMate 9ER: an open-label, randomised, phase 3 trial.
Lancet Oncol
; 23(2): 292-303, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35032437
4.
Comparing patient global impression of severity and patient global impression of change to evaluate test-retest reliability of depression, non-small cell lung cancer, and asthma measures.
Qual Life Res
; 31(12): 3501-3512, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-35854060
5.
Scale development with small samples: a new application of longitudinal item response theory.
Qual Life Res
; 27(7): 1721-1734, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29423756
6.
Assessment of Patient-Reported Outcome Instruments to Assess Chronic Low Back Pain.
Pain Med
; 18(6): 1098-1110, 2017 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28340111
7.
Economic Evaluation of Linaclotide for the Treatment of Adult Patients With Chronic Idiopathic Constipation in the United States.
Manag Care
; 25(2): 41-8, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-27008836
8.
Development and validation of the Diabetic Peripheral Neuropathic Pain Impact (DPNPI) measure, a patient-reported outcome measure.
Qual Life Res
; 24(12): 3001-14, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26068732
9.
Introduction to special section: measuring what matters.
Qual Life Res
; 27(1): 1-3, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29177566
10.
General population reference values for the Functional Assessment of Cancer Therapy-Lung and PROMIS-29.
Cancer Med
; 12(11): 12765-12776, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37148552
11.
A Matching-adjusted Indirect Comparison of Nivolumab Plus Cabozantinib Versus Pembrolizumab Plus Axitinib in Patients with Advanced Renal Cell Carcinoma.
Eur Urol Oncol
; 6(3): 339-348, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36842942
12.
First-line nivolumab plus ipilimumab with two cycles of chemotherapy versus chemotherapy alone (four cycles) in metastatic non-small cell lung cancer: CheckMate 9LA 2-year patient-reported outcomes.
Eur J Cancer
; 183: 174-187, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36871487
13.
Five-Year Survival Outcomes With Nivolumab Plus Ipilimumab Versus Chemotherapy as First-Line Treatment for Metastatic Non-Small-Cell Lung Cancer in CheckMate 227.
J Clin Oncol
; 41(6): 1200-1212, 2023 02 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-36223558
14.
Health-Related Quality of Life With Nivolumab Plus Chemotherapy Versus Chemotherapy in Patients With Advanced Gastric/Gastroesophageal Junction Cancer or Esophageal Adenocarcinoma From CheckMate 649.
J Clin Oncol
; 41(35): 5388-5399, 2023 Dec 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37713657
15.
Three-year follow-up and patient-reported outcomes from CheckMate 078: Nivolumab versus docetaxel in a predominantly Chinese patient population with previously treated advanced non-small cell lung cancer.
Lung Cancer
; 165: 71-81, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-35093625
16.
First-Line Nivolumab Plus Ipilimumab Versus Chemotherapy in Advanced NSCLC With 1% or Greater Tumor PD-L1 Expression: Patient-Reported Outcomes From CheckMate 227 Part 1.
J Thorac Oncol
; 16(4): 665-676, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33485960
17.
Symptoms and impacts in anemia of chronic kidney disease.
J Patient Rep Outcomes
; 4(1): 64, 2020 Jul 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-32728779
18.
Development and adaptation of patient-reported outcome measures for patients who experience itch associated with primary biliary cholangitis.
J Patient Rep Outcomes
; 3(1): 2, 2019 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30645706
19.
Mixed-methods development of a new patient-reported outcome instrument for chronic low back pain: part 2-The Patient Assessment for Low Back Pain-Impacts (PAL-I).
Pain
; 159(10): 2066-2075, 2018 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-29889120
20.
Mixed-methods development of a new patient-reported outcome instrument for chronic low back pain: part 1-the Patient Assessment for Low Back Pain - Symptoms (PAL-S).
Pain
; 159(6): 1045-1055, 2018 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-29432327